404 related articles for article (PubMed ID: 9550764)
21. [Stem cell transplantations as a treatment of severe autoimmune diseases].
Jantunen E; Myllykangas-Luosujärvi R; Kaipiainen-Seppänen O; Mahlamäki E; Nousiainen T
Duodecim; 2000; 116(7):721-7. PubMed ID: 12078138
[No Abstract] [Full Text] [Related]
22. The rationale behind autologous autoimmune hematopoietic stem cell transplant conditioning regimens: concerns over the use of total-body irradiation in systemic sclerosis.
Burt RK; Patel D; Thomas J; Yeager A; Traynor A; Heipe F; Arnold R; Marmont A; Collier D; Glatstein E; Snowden J
Bone Marrow Transplant; 2004 Nov; 34(9):745-51. PubMed ID: 15361910
[TBL] [Abstract][Full Text] [Related]
23. Allogeneic HSCT for autoimmune diseases: conventional conditioning regimens.
Nash RA
Bone Marrow Transplant; 2003 Aug; 32 Suppl 1():S77-80. PubMed ID: 12931249
[TBL] [Abstract][Full Text] [Related]
24. Stem cell transplantation for rheumatic autoimmune diseases.
Hügle T; van Laar JM
Arthritis Res Ther; 2008; 10(5):217. PubMed ID: 18947373
[TBL] [Abstract][Full Text] [Related]
25. Hematopoietic stem cell transplants for autoimmune disease: role of EULAR. European League Against Rheumatism.
van de Putte LB; Tyndall A; van den Hoogen FH; Smolen JS
J Rheumatol Suppl; 1997 May; 48():98-9. PubMed ID: 9150128
[TBL] [Abstract][Full Text] [Related]
26. Autologous haematopoietic stem cell transplants for autoimmune disease--feasibility and transplant-related mortality. Autoimmune Disease and Lymphoma Working Parties of the European Group for Blood and Marrow Transplantation, the European League Against Rheumatism and the International Stem Cell Project for Autoimmune Disease.
Tyndall A; Fassas A; Passweg J; Ruiz de Elvira C; Attal M; Brooks P; Black C; Durez P; Finke J; Forman S; Fouillard L; Furst D; Holmes J; Joske D; Jouet J; Kötter I; Locatelli F; Prentice H; Marmont AM; McSweeney P; Musso M; Peter HH; Snowden JA; Sullivan K; Gratwohl A
Bone Marrow Transplant; 1999 Oct; 24(7):729-34. PubMed ID: 10516675
[TBL] [Abstract][Full Text] [Related]
27. Autoimmune disease after autologous hematopoietic stem cell transplantation.
Bohgaki T; Atsumi T; Koike T
Autoimmun Rev; 2008 Jan; 7(3):198-203. PubMed ID: 18190878
[TBL] [Abstract][Full Text] [Related]
28. Treatment of life-threatening autoimmune diseases with myeloablative doses of immunosuppressive agents: experimental background and rationale for ABMT.
Slavin S
Bone Marrow Transplant; 1993 Jul; 12(1):85-8. PubMed ID: 8104072
[TBL] [Abstract][Full Text] [Related]
29. Autologous hematopoietic stem cell transplantation for autoimmune diseases.
Gratwohl A; Passweg J; Bocelli-Tyndall C; Fassas A; van Laar JM; Farge D; Andolina M; Arnold R; Carreras E; Finke J; Kötter I; Kozak T; Lisukov I; Löwenberg B; Marmont A; Moore J; Saccardi R; Snowden JA; van den Hoogen F; Wulffraat NM; Zhao XW; Tyndall A;
Bone Marrow Transplant; 2005 May; 35(9):869-79. PubMed ID: 15765114
[TBL] [Abstract][Full Text] [Related]
30. Reducing transplant-related mortality after allogeneic hematopoietic stem cell transplantation.
Bacigalupo A; Sormani MP; Lamparelli T; Gualandi F; Occhini D; Bregante S; Raiola AM; di Grazia C; Dominietto A; Tedone E; Piaggio G; Podesta M; Bruno B; Oneto R; Lombardi A; Frassoni F; Rolla D; Rollandi G; Viscoli C; Ferro C; Garbarino L; Van Lint MT
Haematologica; 2004 Oct; 89(10):1238-47. PubMed ID: 15477210
[TBL] [Abstract][Full Text] [Related]
31. Adult stem cell transplantation in autoimmune disease.
Tyndall A; Gratwohl A
Curr Opin Hematol; 2009 Jul; 16(4):285-91. PubMed ID: 19465851
[TBL] [Abstract][Full Text] [Related]
32. Adult stem cell treatment of scleroderma.
Tyndall A; Furst DE
Curr Opin Rheumatol; 2007 Nov; 19(6):604-10. PubMed ID: 17917542
[TBL] [Abstract][Full Text] [Related]
33. Preclinical investigations that subserve efforts to employ bone marrow transplantation for rheumatoid or autoimmune diseases.
Good RA; Ikehara S
J Rheumatol Suppl; 1997 May; 48():5-12. PubMed ID: 9150111
[TBL] [Abstract][Full Text] [Related]
34. Intensive methotrexate and cytarabine followed by high-dose chemotherapy with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma: an intent-to-treat analysis.
Abrey LE; Moskowitz CH; Mason WP; Crump M; Stewart D; Forsyth P; Paleologos N; Correa DD; Anderson ND; Caron D; Zelenetz A; Nimer SD; DeAngelis LM
J Clin Oncol; 2003 Nov; 21(22):4151-6. PubMed ID: 14615443
[TBL] [Abstract][Full Text] [Related]
35. Stem cell transplantation for autoimmune diseases.
Gratwohl A; Passweg J; Gerber I; Tyndall A;
Best Pract Res Clin Haematol; 2001 Dec; 14(4):755-76. PubMed ID: 11924920
[TBL] [Abstract][Full Text] [Related]
36. Induction therapy with vincristine, adriamycin, dexamethasone (VAD) and intermediate-dose melphalan (IDM) followed by autologous or allogeneic stem cell transplantation in newly diagnosed multiple myeloma.
Lokhorst HM; Sonneveld P; Cornelissen JJ; Joosten P; van Marwijk Kooy M; Meinema J; Nieuwenhuis HK; van Oers MH; Richel DJ; Segeren CN; Veth G; Verdonck LF; Wijermans PW
Bone Marrow Transplant; 1999 Feb; 23(4):317-22. PubMed ID: 10100574
[TBL] [Abstract][Full Text] [Related]
37. Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis.
Vonk MC; Marjanovic Z; van den Hoogen FH; Zohar S; Schattenberg AV; Fibbe WE; Larghero J; Gluckman E; Preijers FW; van Dijk AP; Bax JJ; Roblot P; van Riel PL; van Laar JM; Farge D
Ann Rheum Dis; 2008 Jan; 67(1):98-104. PubMed ID: 17526554
[TBL] [Abstract][Full Text] [Related]
38. [High-dose chemotherapy of patients with multiple myeloma].
Heyll A; Söhngen D; Aul C; Schneider P; Kobbe G; Bauser U; Quenzel EM; Schneider W
Praxis (Bern 1994); 1998 Jun; 87(25-26):879-83. PubMed ID: 9702091
[TBL] [Abstract][Full Text] [Related]
39. The promise of hematopoietic stem cell transplantation for autoimmune diseases.
Burt RK; Traynor AE; Craig R; Marmont AM
Bone Marrow Transplant; 2003 Apr; 31(7):521-4. PubMed ID: 12692615
[TBL] [Abstract][Full Text] [Related]
40. Clinically demonstrable anti-autoimmunity mediated by allogeneic immune cells favorably affects outcome after stem cell transplantation in human autoimmune diseases.
Hinterberger W; Hinterberger-Fischer M; Marmont A
Bone Marrow Transplant; 2002 Dec; 30(11):753-9. PubMed ID: 12439698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
